Cargando…

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer

BACKGROUND: The role of the dose escalation strategy in brain radiotherapy for small cell lung cancer (SCLC) patients with brain metastases (BMs) has not been identified. This study aims to determine whether an additional radiation boost to whole brain radiation therapy (WBRT) has beneficial effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Han, Xu, Liming, Wang, Youyou, Zhao, Junhua, Xu, Kunpeng, Qi, Jing, Yuan, Zhiyong, Zhao, Lujun, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299519/ https://www.ncbi.nlm.nih.gov/pubmed/30563554 http://dx.doi.org/10.1186/s13014-018-1198-4

Ejemplares similares

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
por: Ni, Meng, et al.
Publicado: (2020)

Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study
por: Ni, Meng, et al.
Publicado: (2020)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Whole-brain radiation therapy for brain metastases: detrimental or beneficial?
por: Gemici, Cengiz, et al.
Publicado: (2015)

Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases
por: Jiang, Aijun, et al.
Publicado: (2019)

3D Radiation Therapy Boost Improves the Outcome of Whole Brain Radiation Therapy Treated RPA II Patients with One or Two Brain Metastases
por: Antoni, Delphine, et al.
Publicado: (2014)

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
por: Zhuang, Hongqing, et al.
Publicado: (2013)

The role of whole brain radiation therapy in the management of melanoma brain metastases
por: Dyer, Michael A, et al.
Publicado: (2014)

Variations in whole brain radiation therapy fractionation for brain metastases in Victoria
por: Chee, Lessandra Yan Shan, et al.
Publicado: (2022)

A Randomized Controlled Open-Label Pilot Study of Simvastatin Addition to Whole-Brain Radiation Therapy in Patients With Brain Metastases
por: El-Hamamsy, Manal, et al.
Publicado: (2016)

Whole-Brain Radiation Therapy With Simultaneous Integrated Boost Versus Whole-Brain Radiation Therapy Plus Stereotactic Radiosurgery for the Treatment of Brain Metastasis From Lung Cancer
por: Lin, Binwei, et al.
Publicado: (2021)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
por: Shinde, Ashwin, et al.
Publicado: (2019)

Integration of stereotactic radiosurgery or whole brain radiation therapy with immunotherapy for treatment of brain metastases
por: Su, Zhou, et al.
Publicado: (2020)

Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score
por: Logie, Natalie, et al.
Publicado: (2017)

Survival and quality of life after whole brain radiotherapy with 3D conformal boost in the treatment of brain metastases
por: Suteu, Patricia, et al.
Publicado: (2019)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023)

Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery
por: Dong, Xiaotao, et al.
Publicado: (2023)

Predictors for Long-Term Survival Free from Whole Brain Radiation Therapy in Patients Treated with Radiosurgery for Limited Brain Metastases
por: Gorovets, Daniel, et al.
Publicado: (2015)

Feasibility of simultaneous integrated boost with forward intensity-modulated radiation therapy for multiple brain metastases
por: Ni, Lingqin, et al.
Publicado: (2014)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1–3 cerebral metastases
por: Schüttrumpf, Lars Hendrik, et al.
Publicado: (2014)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
por: Khan, Muhammad, et al.
Publicado: (2019)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy
por: Wu, San-Gang, et al.
Publicado: (2016)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
por: Yang, R.F., et al.
Publicado: (2017)

Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases
por: Xu, Yuan, et al.
Publicado: (2022)

Clinical Features of Brain Metastases in Small Cell Lung Cancer: an Implication for Hippocampal Sparing Whole Brain Radiation Therapy()
por: Guo, Wen-Long, et al.
Publicado: (2016)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study
por: Khan, Muhammad, et al.
Publicado: (2021)

Fractionated Stereotactic Radiation Therapy Using Volumetric Modulated Arc Therapy in Patients with Solitary Brain Metastases
por: Zhou, Chong, et al.
Publicado: (2020)

Stereotactic Radiation Therapy for Brain Metastases: Factors Affecting Outcomes and Radiation Necrosis
por: Barillaro, Angela, et al.
Publicado: (2023)

Radiation Necrosis – A Growing Problem in a Case of Brain Metastases Following Whole Brain Radiotherapy and Stereotactic Radiosurgery
por: Song, Yee Pei, et al.
Publicado: (2018)

Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis
por: Gong, Linlin, et al.
Publicado: (2019)

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival
por: Teckie, Sewit, et al.
Publicado: (2013)

Fractionated stereotactic radiation therapy for intact brain metastases
por: Marcrom, Samuel R., et al.
Publicado: (2017)

Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
por: Vellayappan, Balamurugan, et al.
Publicado: (2018)

Efficacy and safety of apatinib combined with whole-brain radiation therapy with a simultaneous integrated boost for brain metastases from non-small cell lung cancer: a multicenter retrospective study
por: Ma, Jia, et al.
Publicado: (2022)

Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy
por: Zeng, Yin-duo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vet6rfsk1kfhtcrfmho2feauau